No evidence of HIV pol gene in spinal cord tissues in sporadic ALS by real-time RT-PCR

Amyotrophic Lateral Sclerosis

Volumn 11, Issue 1-2, 2010, Pages 91-96

  Kim, Young Joo ^a,b   Fan, Yuxin ^a,c   Laurie, Patrick ^a,d   Kim, Jae Mun Hugo ^a   Ravits, John ^a,e  

^a BENAROYA RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c TEXAS CHILDREN S HOSPITAL   (United States)

^d Pathology Department   (United Kingdom)

^e VIRGINIA MASON MEDICAL CENTER   (United States)

Author keywords

ALS; HIV; Neuropathology; PCR; Retroviruses; RNA; Viruses

Indexed keywords

PROTEIN; PROTEIN PO1; RNA; UNCLASSIFIED DRUG;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE SEQUENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MALE; NERVOUS SYSTEM; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SPINAL CORD; SPINAL CORD VENTRAL HORN; SPORADIC AMYOTROPHIC LATERAL SCLEROSIS; VIRUS DETECTION;

AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; NERVE DEGENERATION; POL GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SPINAL CORD;

EID: 77649313773     PISSN: 17482968     EISSN: 1471180X     Source Type: Journal    
DOI: 10.3109/17482960902835988     Document Type: Article

References (40)

1. Rowland LP, Shneider NA. Amyotrophic lateral sclerosis. N Engl J Med. 2001;344:1688-700.
2. Hoffman PM, Festoff BW, Giron LT Jr, Hollenbeck LC, Garruto RM, Ruscetti FW. Isolation of LAV/HTLV-III from a patient with amyotrophic lateral sclerosis. N Engl J Med. 1985;313:324-3.
3. Verma RK, Ziegler DK, Kepes JJ. HIV-related neuromuscular syndrome simulating motor neuron disease. Neurology. 1990;40:544-6.
4. Kuroda Y, Sugihara H. Autopsy report of HTLV-I-associated myelopathy presenting with ALS-like manifestations. Journal of Neurological Sciences. 1991;106:199-205.
5. King EW. Does a retrovirus cause amyotrophic lateral sclerosis? Annals of Neurology. 1991;30:431-3.
6. Jubelt B. Motor neuron disease and viruses: poliovirus, retroviruses, and lymphomas. Current Opinion in Neurology and Neurosurgery. 1992;5:655-8.
7. Westarp ME, Bartmann P, Rossle J, Geiger E, Westphal K-P, Schreiber H, et al. Antiretroviral therapy in sporadic adult amyotrophic lateral sclerosis. Neuroreport. 1993;4:819-22.
8. Huang PP, Chin R, Song S, Lasoff S. Lower motor neuron dysfunction associated with human immunodeficiency virus infection. Arch Neurol. 1993;50:1328-30.
9. Ferrante P, Westarp ME, Mancuso R, Puricelli S, Westarp MP, Mini M. HTLV tax-rex DNA and antibodies in idiopathic amyotrophic lateral sclerosis. Journal of the Neurological Sciences. 1995;129:140-4.
10. Westarp ME, Ferrante P, Perron H, Bartmann P, Kornhuber HH. Sporadic ALS/MND: a global nuerodegeneration with retroviral involvement? J Neurol Sci. 1995;129:145-7.
11. Love S. The search for a transmissible agent in ALS. Brain Pathol. 1996;6:99-100.
12. Galassi G, Gentilini M, Ferrari S, Ficarra G, Zonari P, Mongiardo N, et al. Motor neuron disease and HIV-1 infection in a 30-year-old HIV-positive heroin abuser; a causal relationship? Clin Neuropathol. 1998;17:131-5.
13. Matsuzaki T, Nakagawa M, Nagai M, Nobuhara Y, Usuju K, Higuchi I, et al. HTLV-I-associated myelopathy (HAM)/ tropical spastic pararesis (TSP) with amyotrophic lateral sclerosis-like manifestations. Journal of NeuroVirology. 2000;6:544-8.
14. Sastre-Garriga J, Tintore M, Raguer N, Ruiz I, Montalban X, Codina A. Lower motor neuron disease in a HIV-2 infected woman. J Neurol. 2000;247:718-9.
15. Moulignier A, Pialoux G, Rozenbaum W. Reversible ALSlike disorder in HIV infection. Neurology. 2001;57:995- 1001.
16. MacGowan DJL, Scelsa SN, Waldron M. An ALS-like syndrome with new HIV infection and complete response to antiretroviral therapy. Neurology. 2001;57:1094-7.
17. Von Geisen HJ, Kaiser R, Koller H, Wetzel K, Arendt G. Reversible ALS-like disorder in HIV infection. An ALS-like syndrome with new HIV infection and complete response to antiretroviral therapy. Neurology. 2002;59:474.
18. Pearl D, Noursadeghi M, Manji H, Edwards S, Miller R. Lower motor neuron syndrome and HIV infection. Sex Transm Infect. 2002;79:351.
19. Zoccolella S, Carbonara S, Minerva D, Palagano G, Bruno F, Ferrannini E, et al. A case of concomitant amyotrophic lateral sclerosis and HIV infection. Eur J Neurol. 2002;9:180-2. (Pubitemid 35013937)
20. Sinha S, Mathews T, Arunodaya GR, Siddappa NB, Ranga U, Desai A, clade-C-associated HIV-1, et al. 'ALS'-like disorder: first report from India. J Neurol Sci. 2004;224: 97-100.
21. Silva MTT, Leite ACC, Alamy AH, Chimelli L, Andrada- Serpa MJ, Araujo AQC. ALS syndrome in HTLV-I infection. Neurology. 2005;65:1332-3.
22. Verma A, Berger JR. ALS syndrome in patients with HIV-1 infection. Journal of the Neurological Sciences. 2006;240: 59-64.
23. Andrews WD, Tuke PW, Al-Chalabi A, Gaudin P, Ijaz S, Parton MJ, et al. Detection of reverse transcriptase activity in the serum of patients with motor neuron disease. Journal of Medical Virology. 2000;61:527-32.
24. Steele AJ, Al-Chalabi A, Ferrante K, Cudkowicz ME, Brown RHJr, Garson JA. Detection of serum reverse transcriptase activity in patients with ALS and unaffected blood relatives. Neurology. 2005;64:454-8.
25. MacGowan DJL, Scelsa SN, Imperato TE, Liu K-N, Baron P, Polsky B. A controlled study of reverse transcriptase in serum and CSF of HIV-negative patients with ALS. Neurology. 2007;68:1944-6.
26. McCormick AL, Brown RH, Cudkowicz ME, Al-Chalabi A, Garson JA. Quantification of reverse transcriptase in ALS and elimination of a novel retroviral candidate. Neurology. 2008;70:278-83.
27. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130-3.
28. Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, et al. TDP-43 is a component of ubiquitin-positive taunegative inclusions in frontotempoaral lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun. 2006;351:602-11.
29. Hynd MR, Lewohl JM, Scott HL, Dodd PR. Biochemical and molecular studies using human autopsy brain tissue. Journal of Neurochemistry. 2003;85:543-62.
30. Srinivasan M, Sedmak D, Jewell S. Effect of fixatives and tissue processing on the content and integrity of nucleic acids. American Journal of Pathology. 2002;161:1961-71.
31. Ravits J, Laurie P, Fan Y, Moore DH. Implications of ALS focality: rostral-caudal distribution of lower motor neuron loss post mortem. Neurology. 2007;68:1576-82.
32. Schroeder A, Mueller O, Stocker S, Salowsky R, Leiber M, Gassmann M, et al. The RIN: an RNA integrity number for assigning integrity values to RNA measurements. In: BMC Molecular Biology, 2006. Jan 31;7:3.
33. Ma H. Development application of polymerase chain reaction (PCR). The Journal of American Science. 2005;1:1-47.
34. Gendelman HE, Grant I, Everall IP, Lipton SA, Swindells S. The Neurology of AIDS, 2nd edn. Oxford University Press, 2005. p. 19-20.
35. Dickson DW,Mattiace LA, Jure K, Hutchins K, Lyman WD, Brosnan CF. Microglia in human disease, with an emphasis on acquired immune deficiency syndromes. Lab Invest. 1991;64:135-56.
36. Boven LA. Macrophages and HIV-1-associated dementia. Archivum Immunologiae et Therapiae Experimentalis. 2000;48:273-9.
37. Langford D, Masliah E. Cross-talk between components of the blood-brain barrier and cells of the CNS in microglial activation in AIDS. Brain Pathology. 2001;11:306-12.
38. Scicchitano MS, Dalmas DA, Bertiaus MA, Anderson SM, Turner LR, Thomas RA, et al. Preliminary comparison of quantity, quality, and microarray performance of RNA extracted from formalin-fixed, paraffin-embedded, and unfixed frozen tissue samples. Journal of Histochemistry and Cytochemistry. 2006;54:1229-37.
39. Robertson DL, Hahn BH, Sharp PM. Recombination in AIDS viruses. J Mol Evol. 1995;40:249-59.
40. Cronelissen M, van den Burg R, Zorgdrager F, Lukashov V, Goudsmit J. Pol gene diversity of five human immunodeficiency virus type 1 subtypes: evidence for naturally occuring mutations that contribute to drug resistance, limited recombination patterns, and common ancestry for subtypes B and D. Journal of Virology. 1997;71:6348-58.